{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:40:00Z","timestamp":1777621200111,"version":"3.51.4"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Elective percutaneous coronary intervention (PCI) is performed to relieve symptoms of angina. Identifying patients who will benefit symptomatically after PCI would be clinically advantageous but robust predictors of symptom resolution are ill-defined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Prospective indexing of baseline angina status, clinical, and procedural characteristics were collected over a 5-year period in a regional revascularization registry. At 1-year follow-up, angina resolution was assessed. We performed a stepwise selection algorithm to identify predictors of persistent angina at 1\u2009year.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 777 patients were included in the analysis and the median follow-up was 387\u2009days. Mean age of the cohort was 66.6\u2009years, 23.8% were female and 23.3% had baseline Canadian Cardiovascular Society class 3 or 4 angina. Overall, 13.1% had persistent angina. The only predictor of persistent angina was the presence of a residual chronic total occlusion after PCI with odds ratio of 3.06 (95% confidence interval, 1.81\u20135.17). Residual stenoses 50\u201369%, 70\u201389%, and 90\u201399% were not associated with residual angina after PCI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Most patients achieved symptom resolution with PCI and optimal medical therapy. A residual chronic total occlusion after PCI was associated with persistent angina. Other degrees of stenoses were not associated with persistent angina.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001081","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:01:37Z","timestamp":1624233697000},"page":"98-104","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Predictors of angina resolution after percutaneous coronary intervention in stable coronary artery disease"],"prefix":"10.1097","volume":"33","author":[{"given":"Louis","family":"Verreault-Julien","sequence":"first","affiliation":[{"name":"CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada"},{"name":"Harvard T.H. Chan School of Public Health, Harvard University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital Heart & Vascular Center"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Jung","sequence":"additional","affiliation":[{"name":"CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada"},{"name":"Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Di Santo","sequence":"additional","affiliation":[{"name":"CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada"},{"name":"Faculty of Medicine"},{"name":"School of Epidemiology and Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Simard","sequence":"additional","affiliation":[{"name":"CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada"},{"name":"Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Avram","sequence":"additional","affiliation":[{"name":"CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Hibbert","sequence":"additional","affiliation":[{"name":"CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada"},{"name":"Faculty of Medicine"},{"name":"School of Epidemiology and Public Health"},{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2017.02.001","article-title":"ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.","volume":"69","author":"Patel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"e003971","DOI":"10.1161\/CIRCOUTCOMES.117.003971","article-title":"Predicting the benefits of percutaneous coronary intervention on 1-year angina and quality of life in stable ischemic heart disease: risk models from the COURAGE trial (clinical outcomes utilizing revascularization and aggressive drug evaluation).","volume":"11","author":"Zhang","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease.","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease.","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.120.048194","article-title":"Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials.","volume":"142","author":"Bangalore","year":"2020","journal-title":"Circulation"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"g3859","DOI":"10.1136\/bmj.g3859","article-title":"Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.","volume":"348","author":"Windecker","year":"2014","journal-title":"BMJ"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease.","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI on quality of life in patients with stable coronary disease.","volume":"359","author":"Weintraub","year":"2008","journal-title":"N Engl J Med"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"e953","DOI":"10.4244\/EIJV16I12A174","article-title":"Translating the findings of ISCHEMIA into clinical practice: a challenging START.","volume":"16","author":"Boden","year":"2020","journal-title":"Eurointervention"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease.","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve.","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N Engl J Med"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ehjqcco\/qcv010","article-title":"Prediction of residual angina after percutaneous coronary intervention.","volume":"1","author":"Arnold","year":"2015","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/circ.54.3.947585","article-title":"Letter: grading of angina pectoris.","volume":"54","author":"Campeau","year":"1976","journal-title":"Circulation"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-8703(93)90404-W","article-title":"Angiographic suitability for catheter revascularization of total coronary occlusions in patients from a community hospital setting.","volume":"126","author":"Kahn","year":"1993","journal-title":"Am Heart J"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.amjcard.2004.12.065","article-title":"Effect of chronic total coronary occlusion on treatment strategy.","volume":"95","author":"Christofferson","year":"2005","journal-title":"Am J Cardiol"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jacc.2011.12.007","article-title":"Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry.","volume":"59","author":"Fefer","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00392-009-0013-5","article-title":"Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present day clinical practice.","volume":"98","author":"Werner","year":"2009","journal-title":"Clin Res Cardiol"},{"key":"R19-20250729","first-page":"637","article-title":"Prevalence and management of coronary chronic total occlusions in a tertiary veterans affairs hospital.","volume":"84","author":"Jeroudi","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jcin.2016.04.031","article-title":"Prognostic impact of chronic total occlusions: a report from SCAAR (Swedish Coronary Angiography and Angioplasty Registry).","volume":"9","author":"R\u00e5munddal","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1093\/eurheartj\/ehv450","article-title":"Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions.","volume":"36","author":"Tomasello","year":"2015","journal-title":"Eur Heart J"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.amjcard.2016.07.023","article-title":"Epidemiology, management strategies, and outcomes of patients with chronic total coronary occlusion.","volume":"118","author":"Azzalini","year":"2016","journal-title":"Am J Cardiol"},{"key":"R23-20250729","first-page":"9","article-title":"The myocardium supplied by a chronic total occlusion is a persistently ischemic zone.","volume":"83","author":"Sachdeva","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehl270","article-title":"The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction.","volume":"27","author":"Werner","year":"2006","journal-title":"Eur Heart J"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ahj.2010.04.015","article-title":"Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis.","volume":"160","author":"Joyal","year":"2010","journal-title":"Am Heart J"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.amjcard.2015.02.038","article-title":"Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions.","volume":"115","author":"Christakopoulos","year":"2015","journal-title":"Am J Cardiol"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jcin.2017.05.065","article-title":"Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO Registry (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures).","volume":"10","author":"Sapontis","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0735-1097(03)00312-7","article-title":"Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE).","volume":"41","author":"Olivari","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/eurheartj\/ehy220","article-title":"A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.","volume":"39","author":"Werner","year":"2018","journal-title":"Eur Heart J"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.jacc.2009.11.096","article-title":"Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation.","volume":"55","author":"Tonino","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCINTERVENTIONS.111.965509","article-title":"Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease.","volume":"5","author":"G\u00f6ssl","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R32-20250729","first-page":"S978","article-title":"Abstract 4602: complete revascularization in patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: a meta analysis.","volume":"120","author":"Bangalore","year":"2009","journal-title":"Circulation"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis.","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2017.07.105","article-title":"Angina after percutaneous coronary intervention: the need for precision medicine.","volume":"248","author":"Niccoli","year":"2017","journal-title":"Int J Cardiol"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehy857","article-title":"Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.","volume":"40","author":"Crea","year":"2019","journal-title":"Eur Heart J"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"III27","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis.","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcmg.2018.11.036","article-title":"Coronary microvascular dysfunction: clinical considerations and noninvasive diagnosis.","volume":"13","author":"Schindler","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"e002666","DOI":"10.1161\/CIRCIMAGING.114.002666","article-title":"Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis.","volume":"8","author":"Takx","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.amjcard.2010.10.073","article-title":"Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.","volume":"107","author":"Banerjee","year":"2011","journal-title":"Am J Cardiol"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamacardio.2018.2849","article-title":"The evolution of patient-reported outcomes in clinical trials and management of patients with coronary artery disease: 20 years with the Seattle Angina Questionnaire.","volume":"3","author":"Spertus","year":"2018","journal-title":"JAMA Cardiol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:05:25Z","timestamp":1753812325000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001081","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,18]]}}}